Researchers have uncovered a crucial enzyme responsible for a specific chemical modification linked to the growth of a severe ...

From bloodshot eyes to swollen fingers, these seemingly innocent symptoms could signal something more serious, like a blood disorder or an autoimmune disease.

This condition, known as leukemia complicated by CNS lesions (LCL), encompasses both CNS leukemia (CNSL) and secondary CNS lesions caused by leukemia therapy, such as infections or neuroinflammatory ...

June marks AML Awareness Month. It is a time to understand acute myeloid leukaemia. AML is a blood cancer needing quick action. Early signs like fatig ...

A new blood test can detect leukemia and blood aging risks non-invasively, potentially replacing painful bone marrow biopsies ...

Brittne Largent put off going to the doctor initially until her pain became unbearable. She thought she had Sciatica, but a trip to her physician led to a diagnosis of leukemia.

What if a blood test could reveal the pace of our aging—and the diseases that may lie ahead? The labs of Profs. Liran Shlush ...

Panelists emphasize that the approval of menin inhibitors has transformed the treatment landscape for KMT2A-rearranged acute ...

Panelists report that the AUGMENT-101 trial demonstrated meaningful clinical benefits of menin inhibitors in ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Revuforj (revumenib) is an oral, first-in-class, selective menin inhibitor that is FDA approved for the treatment of relapsed or refractory (R/R) acute leukemia with a lysine methyltransferase 2A gene ...